Frailty as an INstrument for Evaluation of Elderly Patients With Non ST Elevation Myocardial Infarction (NSTEMI)
FINE75+
1 other identifier
observational
307
1 country
1
Brief Summary
The purpose of this study is to describe patients, 75 years old or older, with Non ST Elevation Myocardial Infarction (NSTEMI) especially regarding the following variables: cardiovascular risk, co-morbidity and frailty. The investigators hypothesize that the degree of frailty influences the benefit from coronary angiography and the possible invasive treatment which can follow.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 14, 2010
CompletedFirst Posted
Study publicly available on registry
January 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedMarch 31, 2015
March 1, 2015
1.7 years
January 14, 2010
March 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The composite of death from any cause, myocardial infarction, revascularization due to ischemia, hospitalization from any cause, major bleeding, stroke/TIA and need for dialysis by one month after inclusion.
One month after inclusion
Secondary Outcomes (1)
The composite of major bleeding, stroke/TIA and need for dialysis by one month after inclusion.
One month after inclusion
Study Arms (1)
NSTEMI75+
Patients, 75 years old or older, with Non ST Elevation Myocardial Infarction (NSTEMI)
Eligibility Criteria
Consecutive evaluable patients, 75 years old or older, with diagnosed NSTEMI, and cared for at one of the following hospital care units in the University Hospital of Linköping and the County Hospitals in Trollhättan (NÄL-Uddevalla) and Jönköping (Ryhov): cardiology, acute medicine, geriatrics, other internal medicine unit.
You may qualify if:
- Patients, 75 years old or older, with diagnosed NSTEMI, and cared for at one of the following hospital care units: cardiology, acute medicine, geriatrics, other internal medicine unit.
You may not qualify if:
- Not willing to participate.
- Non-evaluable patient due to communication problems and insufficient clinical information for the judgement of frailty (CFS).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Linkoeping Universitylead
- Medical Research Councilcollaborator
Study Sites (1)
The Center for Medical Technology Assessment/IMH, Linkoeping University
Linköping, Östergötland County, 58183, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Niklas G Ekerstad, MD
Linkoeping University, Sandbäcksgatan 7, 58183 Linkoeping, Sweden
- PRINCIPAL INVESTIGATOR
Joakim Alfredsson, PhD
Department of Cardiology, University Hospital of Linkoeping, 58183 Linkoeping, Sweden
- PRINCIPAL INVESTIGATOR
Marcus Lindenberger, PhD
Department of Cardiology, County Hospital Ryhov, 551 85 Joenkoeping, Sweden
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD,PhD
Study Record Dates
First Submitted
January 14, 2010
First Posted
January 15, 2010
Study Start
October 1, 2009
Primary Completion
June 1, 2011
Study Completion
March 1, 2012
Last Updated
March 31, 2015
Record last verified: 2015-03